Switch theme
Sign up to access all valuation multiples
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
1990
7.0K+
LTM Revenue $694M
LTM EBITDA $84.3M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
U.S. Physical Therapy has a last 12-month revenue of $694M and a last 12-month EBITDA of $84.3M.
In the most recent fiscal year, U.S. Physical Therapy achieved revenue of $671M and an EBITDA of $86.9M.
U.S. Physical Therapy expects next 12-month revenue of XXX and NTM EBITDA of XXX
See U.S. Physical Therapy valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $605M | $671M | XXX | XXX | XXX |
| Gross Profit | $112M | $122M | XXX | XXX | XXX |
| Gross Margin | 19% | 18% | XXX | XXX | XXX |
| EBITDA | $74.4M | $86.9M | XXX | XXX | XXX |
| EBITDA Margin | 12% | 13% | XXX | XXX | XXX |
| Net Profit | $28.3M | $14.7M | XXX | XXX | XXX |
| Net Margin | 5% | 2% | XXX | XXX | XXX |
| Net Debt | $152M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, U.S. Physical Therapy's stock price is $70.
U.S. Physical Therapy has current market cap of $1.1B, and EV of $1.3B.
See U.S. Physical Therapy trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.1B | XXX | XXX | XXX | XXX | $2.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, U.S. Physical Therapy has market cap of $1.1B and EV of $1.3B.
U.S. Physical Therapy's trades at 1.9x LTM EV/Revenue multiple, and 15.6x LTM EBITDA.
Analysts estimate U.S. Physical Therapy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for U.S. Physical Therapy and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 15.1x | XXX | XXX | XXX |
| P/E | 40.1x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | 20.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpU.S. Physical Therapy's NTM/LTM revenue growth is 10%
U.S. Physical Therapy's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $8K for the same period.
Over next 12 months, U.S. Physical Therapy's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate U.S. Physical Therapy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for U.S. Physical Therapy and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 17% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 23% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $8K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 9% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
U.S. Physical Therapy acquired XXX companies to date.
Last acquisition by U.S. Physical Therapy was XXXXXXXX, XXXXX XXXXX XXXXXX . U.S. Physical Therapy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was U.S. Physical Therapy founded? | U.S. Physical Therapy was founded in 1990. |
| Where is U.S. Physical Therapy headquartered? | U.S. Physical Therapy is headquartered in United States of America. |
| How many employees does U.S. Physical Therapy have? | As of today, U.S. Physical Therapy has 7.0K+ employees. |
| Who is the CEO of U.S. Physical Therapy? | U.S. Physical Therapy's CEO is Mr. Christopher J. Reading. |
| Is U.S. Physical Therapy publicy listed? | Yes, U.S. Physical Therapy is a public company listed on NYS. |
| What is the stock symbol of U.S. Physical Therapy? | U.S. Physical Therapy trades under USPH ticker. |
| When did U.S. Physical Therapy go public? | U.S. Physical Therapy went public in 1992. |
| Who are competitors of U.S. Physical Therapy? | Similar companies to U.S. Physical Therapy include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of U.S. Physical Therapy? | U.S. Physical Therapy's current market cap is $1.1B |
| What is the current revenue of U.S. Physical Therapy? | U.S. Physical Therapy's last 12-month revenue is $694M. |
| What is the current EBITDA of U.S. Physical Therapy? | U.S. Physical Therapy's last 12-month EBITDA is $84.3M. |
| What is the current EV/Revenue multiple of U.S. Physical Therapy? | Current revenue multiple of U.S. Physical Therapy is 1.9x. |
| What is the current EV/EBITDA multiple of U.S. Physical Therapy? | Current EBITDA multiple of U.S. Physical Therapy is 15.6x. |
| What is the current revenue growth of U.S. Physical Therapy? | U.S. Physical Therapy revenue growth between 2023 and 2024 was 11%. |
| Is U.S. Physical Therapy profitable? | Yes, U.S. Physical Therapy is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
